Tag: Calcitonin gene-related peptide receptor antagonists

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Calcitonin gene-related peptide receptor antagonists

Biohaven Highlights Neuroscience Advancements with 22 Presentations at the 2021 American ...

Added to Collection on: 2021-04-13 11:26:15

Tags for this article:

Calcitonin gene-related peptide receptor antagonists
Chemical compounds
Migraine
Carbamates
Organic compounds
Piperidines
Branches of biology
Rimegepant
CALCRL
Calcitonin gene-related peptide
Neurogenic inflammation
Biohaven Pharmaceutical Holding Company Ltd.

Click the tags to see associated articles and topics

View Article Details
Ubrogepant in the Acute Management of Migraine: A Narrative Review

Added to Collection on: 2021-04-26 23:15:00

Tags for this article:

Drugs
Monoclonal antibodies
Triptans
Clinical medicine
Health care
Migraine
Calcitonin gene-related peptide receptor antagonists
Calcitonin gene-related peptide
Sumatriptan
Neurogenic inflammation
Paracetamol
Erenumab
ubrogepant

Click the tags to see associated articles and topics

View Article Details
Utilizing CGRP Antagonists for Non-Migraine Indications

Added to Collection on: 2021-05-05 18:45:51

Tags for this article:

Branches of biology
Calcitonin gene-related peptide receptor antagonists
Calcitonin gene-related peptide
Neuropeptides
CALCRL
RAMP1
Migraine
Calcitonin
Orofacial pain
Neurogenic inflammation

Click the tags to see associated articles and topics

View Article Details
Eli Lilly pins injectable migraine med Emgality against Biohaven's oral rival Nurtec ODT in head-to ...

Added to Collection on: 2021-06-15 10:50:00

Tags for this article:

Monoclonal antibodies
Migraine
Health care
Calcitonin gene-related peptide receptor antagonists
Life Sciences
Clinical medicine
Calcitonin gene-related peptide
Neuropeptides
Galcanezumab
Prevention of migraines
Erenumab
Rimegepant
Eli Lilly
Biohaven Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Lilly Announces Head-to-Head Study Comparing Once-Monthly Emgality® with Every-Other-Day ...

Added to Collection on: 2021-06-15 10:41:15

Tags for this article:

Branches of biology
Clinical medicine
Monoclonal antibodies
Symptoms and signs
Headaches
Calcitonin gene-related peptide receptor antagonists
Migraine
Breakthrough therapy
Galcanezumab
Calcitonin gene-related peptide
Cluster headache
International Classification of Headache Disorders
Eli Lilly and Company
Calcitonin

Click the tags to see associated articles and topics

View Article Details
Lilly Launches Head-to-Head Trial in Quest to Bolster Migraine Preventive Drug

Added to Collection on: 2021-06-15 16:30:00

Tags for this article:

Monoclonal antibodies
Calcitonin gene-related peptide receptor antagonists
Life Sciences
Health care
Drugs
Breakthrough therapy
Galcanezumab
Calcitonin gene-related peptide
Erenumab
Migraine
Teva Pharmaceuticals
Rimegepant
Eli Lilly
Eli Lilly and Company

Click the tags to see associated articles and topics

View Article Details
Migraine Prevention Drug Shows Rapid Benefits During Attack

Added to Collection on: 2021-06-15 21:22:30

Tags for this article:

Drugs
Health care
Migraine
Clinical medicine
Monoclonal antibodies
Calcitonin gene-related peptide receptor antagonists
Eptinezumab
Piperidines
Triptans
Calcitonin gene-related peptide
Lasmiditan
Placebo

Click the tags to see associated articles and topics

View Article Details
Head-to-Head Study Comparing Once-Monthly Galcanezumab-gnlm With Every-Other-Day ...

Added to Collection on: 2021-06-23 13:52:30

Tags for this article:

Monoclonal antibodies
Calcitonin gene-related peptide receptor antagonists
Calcitonin gene-related peptide
Neuropeptides
Branches of biology
Symptoms and signs
Clinical medicine
Galcanezumab
Migraine
Headaches
CALCRL
International Classification of Headache Disorders

Click the tags to see associated articles and topics

View Article Details
Pharmacologic Treatment of Migraine: Current and Emerging Therapies

Added to Collection on: 2021-06-29 15:56:15

Tags for this article:

Monoclonal antibodies
Drugs
Migraine
Calcitonin gene-related peptide receptor antagonists
Chemical compounds
Clinical medicine
Piperidines
Calcitonin gene-related peptide
Neuropeptides
Erenumab
Triptan
Lasmiditan

Click the tags to see associated articles and topics

View Article Details
Migraine Treatment Market Outlook 2025–2035 | Trends, Dynamics, and North America Insights

Added to Collection on: 2025-08-21 10:59:07

Tags for this article:

Migraine
Calcitonin gene-related peptide receptor antagonists
Piperidines
Medicinal chemistry
Therapy
Management of migraine
Calcitonin gene-related peptide
Triptan
Rimegepant
Medication overuse headache
Telehealth
Vagus nerve stimulation
United States

Click the tags to see associated articles and topics

View Article Details
Book a Demo